MedTrace Logo

Reward Circuit Targeted iTBS

NCT05468853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-01-27

Study results available
· View outcomes & findings →

Summary

The objective of this study is to examine the effect of intermittent theta-burst transcranial magnetic stimulation (iTBS) targeting the reward circuit.

Conditions

  • Transcranial Magnetic Stimulation

Interventions

DEVICE

transcranial magnetic stimulation

Transcranial magnetic stimulation delivered to the scalp targeting medial prefrontal cortex

DEVICE

transcranial magnetic stimulation

Transcranial magnetic stimulation delivered to the inion

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Florida State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2024-09-18
Completion
2024-09-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05468853 on ClinicalTrials.gov